President & CEO

Group Vice President, Head Inflammation and AutoImmunity Group

This Incyte Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Thursday

Incyte Announces Positive CHMP Opinion for Zynyz® (retifanlimab) for First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)

Insider Decision Unfolding At Incyte: Khairie Mohamed Issa Exercises Options, Resulting In $0

Engaging In Insider Activity, Patrick Mayes At Incyte Exercises Options Worth $0

Associate Director, MSL Training, IAI

Incyte is a biopharmaceutical company focused on developing novel medicines for oncology and inflammation. The Associate Director, Medical Affairs Training, will design and implement a training plan that aligns with the Medical Affairs strategy, ensuring the Medical team receives comprehensive training and support for their roles.

Associate Director, Msl Training, Iai in united states (1000+)

Associate Director, MSL Training, IAI